Identification of miR-16-5p and miR-155-5p microRNAs differentially expressed in circulating leukocytes of pregnant women with polycystic ovary syndrome and gestational diabetes.

Pregnant women with polycystic ovary syndrome (PCOS) are at increased risk of gestational diabetes (GDM). We aimed to assess the expressions of candidate microRNAs (miRs) in leukocytes of pregnant women with PCOS and GDM. Using real-time quantitative PCR method, miR-16-5p and miR-155-5p were examined from PCOS ( = 17), GDM ( = 14), GDM + PCOS ( = 11), and controls ( = 27).